Vitrectomy in the Management of Diabetic Macular Edema

Luis J. Haddock, Deanna Lyttle

Research output: Contribution to journalReview articlepeer-review


The vitreous has been shown to be a contributing factor in the pathogenesis of tractional and non-tractional diabetic macular edema (DME). Modern techniques in pars plana vitrectomy (PPV) allow the safe removal of the vitreous with the posterior hyaloid which relieves vitreomacular traction and removes inflammatory factors believed to play a role in DME. Additional techniques such as endolaser, peeling of epiretinal membranes and the internal limiting membrane can also be performed at the time of PPV. Satisfactory visual and anatomic outcomes have been achieved in DME cases refractory to non-surgical therapies. The purpose of this article is to review the relevant literature related to the use of vitrectomy in the treatment of DME and provide an update of current practices.

Original languageEnglish (US)
Pages (from-to)71-74
Number of pages4
JournalCurrent Ophthalmology Reports
Issue number2
StatePublished - Jun 1 2016


  • Diabetic macular edema (DME)
  • Epiretinal membrane (ERM)
  • Internal limiting membrane (ILM)
  • Pars plana vitrectomy (PPV)
  • Posterior vitreous detachment (PVD)
  • Vitreomacular traction (VMT)

ASJC Scopus subject areas

  • Ophthalmology


Dive into the research topics of 'Vitrectomy in the Management of Diabetic Macular Edema'. Together they form a unique fingerprint.

Cite this